Unicycive Therapeutics (UNCY) Total Debt (2020 - 2024)

Unicycive Therapeutics' (UNCY) quarterly Total Debt came in at $208000.0 in Q1 2024, up 101.94% on a QoQ basis from $103000.0 in Q3 2021.

Unicycive Therapeutics (UNCY) Total Debt (2020 - 2024) Analysis & Trends

Unicycive Therapeutics (UNCY) has 3 years of Total Debt data on file, last reported at $208000.0 in Q1 2024.

Quarterly Total Debt changed N/A year-over-year to $208000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $208000.0 (changed N/A YoY) and the FY2020 annual result came in at $967000.0, changed N/A from the prior year.
Total Debt advanced to $208000.0 in Q1 2024, from $103000.0 in the prior quarter.
In the past five years, Total Debt ranged from a high of $967000.0 in Q4 2020 to a low of $103000.0 in Q3 2021.
A 3-year average of $544750.0 and a median of $554500.0 in 2021 frame the typical range for Total Debt.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	1.99 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	591.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	1.07 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	770.36 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	546.77 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	9.34 Bn
10	Unicycive Therapeutics	151.01 Mn	151.01 Mn	-	-

Download Data